Immunotherapies for malignant glioma

被引：122

作者：

Boussiotis, Vassiliki A. ^{[1
,2
,3
]}

Charest, Alain ^{[2
,3
,4
]}

机构：

[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA USA

[2] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA

[3] Harvard Med Sch, Beth Israel Deaconess Canc Ctr, Boston, MA 02115 USA

[4] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Genet, Boston, MA 02115 USA

来源：

ONCOGENE | 2018年 / 37卷 / 09期

关键词：

CENTRAL-NERVOUS-SYSTEM; REGULATORY T-CELLS; CANCER STEM-CELLS; NEWLY-DIAGNOSED GLIOBLASTOMA; CHIMERIC ANTIGEN RECEPTOR; BLOOD-BRAIN-BARRIER; TUMOR-ASSOCIATED MACROPHAGES; IMMUNE CHECKPOINT BLOCKADE; GROWTH-FACTOR RECEPTOR; MICROGLIAL CELLS;

D O I：

10.1038/s41388-017-0024-z

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

070307 [化学生物学]; 071010 [生物化学与分子生物学];

摘要：

Glioblastoma multiforme (GBM) is a highly malignant primary brain cancer with a dreadful overall survival and for which treatment options are limited. Recent breakthroughs in novel immune-related treatment strategies for cancer have spurred interests in usurping the power of the patient's immune system to recognize and eliminate GBM. Here, we discuss the unique properties of GBM's tumor microenvironment, the effects of GBM standard on care therapy on tumor-associated immune cells, and review several approaches aimed at therapeutically targeting the immune system for GBM treatment. We believe that a comprehensive understanding of the intricate micro-environmental landscape of GBM will abound into the development of novel immunotherapy strategies for GBM patients.

引用

收藏

页码：1121 / 1141

页数：21

相关论文

共 202 条

[91]

Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level [J].

Kmiecik, Justyna ;

Poli, Aurelie ;

Brons, Nicolaas H. C. ;

Waha, Andreas ;

Eide, Geir Egil ;

Enger, Per Oyvind ;

Zimmer, Jacques ;

Chekenya, Martha .

JOURNAL OF NEUROIMMUNOLOGY, 2013, 264 (1-2) :71-83

[92]

Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor [J].

Kochenderfer, James N. ;

Dudley, Mark E. ;

Kassim, Sadik H. ;

Somerville, Robert P. T. ;

Carpenter, Robert O. ;

Stetler-Stevenson, Maryalice ;

Yang, James C. ;

Phan, Giao Q. ;

Hughes, Marybeth S. ;

Sherry, Richard M. ;

Raffeld, Mark ;

Feldman, Steven ;

Lu, Lily ;

Li, Yong F. ;

Ngo, Lien T. ;

Goy, Andre ;

Feldman, Tatyana ;

Spaner, David E. ;

Wang, Michael L. ;

Chen, Clara C. ;

Kranick, Sarah M. ;

Nath, Avindra ;

Nathan, Debbie-Ann N. ;

Morton, Kathleen E. ;

Toomey, Mary Ann ;

Rosenberg, Steven A. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (06) :540-U31

[93]

LAFFERTY KJ, 1978, BLOOD CELLS, V4, P395

[94]

Cancer stem cells in glioblastoma [J].

Lathia, Justin D. ;

Mack, Stephen C. ;

Mulkearns-Hubert, Erin E. ;

Valentim, Claudia L. L. ;

Rich, Jeremy N. .

GENES & DEVELOPMENT, 2015, 29 (12) :1203-1217

[95]

Enhancement of antitumor immunity by CTLA-4 blockade [J].

Leach, DR ;

Krummel, MF ;

Allison, JP .

SCIENCE, 1996, 271 (5256) :1734-1736

[96]

Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients [J].

LeBlanc, Amy K. ;

Mazcko, Christina ;

Brown, Diane E. ;

Koehler, Jennifer W. ;

Miller, Andrew D. ;

Miller, C. Ryan ;

Bentley, R. Timothy ;

Packer, Rebecca A. ;

Breen, Matthew ;

Boudreau, C. Elizabeth ;

Levine, Jonathan M. ;

Simpson, R. Mark ;

Halsey, Charles ;

Kisseberth, William ;

Rossmeisl, John H., Jr. ;

Dickinson, Peter J. ;

Fan, Timothy M. ;

Corps, Kara ;

Aldape, Kenneth ;

Puduvalli, Vinay ;

Pluhar, G. Elizabeth ;

Gilbert, Mark R. .

NEURO-ONCOLOGY, 2016, 18 (09) :1209-1218

[97]

Infusions of Allogeneic Natural Killer Cells as Cancer Therapy [J].

Leung, Wing .

CLINICAL CANCER RESEARCH, 2014, 20 (13) :3390-3400

[98]

Pericyte loss and microaneurysm formation in PDGF-B-deficient mice [J].

Lindahl, P ;

Johansson, BR ;

Leveen, P ;

Betsholtz, C .

SCIENCE, 1997, 277 (5323) :242-245

[99]

Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall [J].

Lindblom, P ;

Gerhardt, H ;

Liebner, S ;

Abramsson, A ;

Enge, M ;

Hellström, M ;

Bäckström, G ;

Fredriksson, S ;

Landegren, U ;

Nyström, HC ;

Bergström, G ;

Dejana, E ;

Östman, A ;

Lindahl, P ;

Betsholtz, C .

GENES & DEVELOPMENT, 2003, 17 (15) :1835-1840

[100]

Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome [J].

Ling, Yun ;

Cao, Xiangshan ;

Yu, Ziqiang ;

Ruan, Changgeng .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (04) :310-316

← 5 6 7 8 9 10 11 12 13 14 →